IN THE NEWS

THE LATEST NEWS

Amgen Ventures Invests in GNS Healthcare to Advance Applications of its REFS™ Causal Machine Learning and Simulation AI Platforms

FierceBiotech features Alexion-GNS Partnership Targeting Rare Diseases

Rare Disease Report Covers Alexion-GNS REFS Licensing Agreement

GNS Co-Founder Iya Khalil Interviewed in The Pink Sheet

GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases

Sema4 and GNS Healthcare Announce Collaboration Using REFS™ Causal Machine Learning and Simulation AI Platform

GNS Healthcare Uncovers Novel Targets for Triple-Negative Breast Cancer Using Causal Machine Learning and Simulation Platform REFS™

GNS Healthcare and Regence Blue Cross Blue Shield Co-Present Machine Learning Enhanced Advanced Illness Program at Annual Blues National Summit

GNS Taps Nationally Regarded Epidemiologist to Put Discoveries From Causal Machine Learning and Simulation Platform in ‘Clinical Context’

GNS Prominently Featured in BioCentury Cover Story on Use of Machine Learning by Pharma